Vertex Q3 Net Income Falls 40% to $653.6 Million
Vertex Pharmaceuticals reported Q3 2026 net income of $653.6 million, down 40% year over year.
Story updates
09:06:29 PM UTC
SquawkNews
Vertex: Nettogewinn sinkt im dritten Quartal 2026 gegenüber Vorjahr um 40 Prozent auf 653.6 Millione
09:20:28 PM UTC
SquawkNews
Vertex reported third-quarter 2026 revenue of $3.44 billion, up 12% year over year, and raised its full-year revenue guidance. GAAP net income was $654 million, while non-GAAP diluted earnings per share were $4.76. The company said growth was driven by its cystic fibrosis portfolio and contribution…